orphenadrine has been researched along with nicotine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Funcke, AB; Lavy, UI; Mulder, D; Nauta, WT; Timmerman, H; van Beek, MC; van Hell, G | 1 |
4 other study(ies) available for orphenadrine and nicotine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Pharmacological properties of tofenacine hydrochloride: N-methyl-2-[(o-methyl-a-phenylbenzyl)oxy]ethylamine hydrochloride.
Topics: Adjuvants, Anesthesia; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Blood Pressure; Body Temperature; Central Nervous System; Coronary Vessels; Diuretics; Drug Synergism; Ethylamines; Female; Guinea Pigs; Hexobarbital; Histamine H1 Antagonists; Locomotion; Male; Mice; Motor Activity; Nicotine; Norepinephrine; Orphenadrine; Parasympatholytics; Pupil; Rats; Respiration; Salivation; Tetrabenazine; Tremorine | 1969 |